GEN vs. NTES, TEAM, ADSK, SNOW, NET, VEEV, EA, TTWO, XYZ, and DDOG
Should you be buying Genesis Healthcare stock or one of its competitors? The main competitors of Genesis Healthcare include NetEase (NTES), Atlassian (TEAM), Autodesk (ADSK), Snowflake (SNOW), Cloudflare (NET), Veeva Systems (VEEV), Electronic Arts (EA), Take-Two Interactive Software (TTWO), Block (XYZ), and Datadog (DDOG). These companies are all part of the "prepackaged software" industry.
Genesis Healthcare vs.
Genesis Healthcare (NYSE:GEN) and NetEase (NASDAQ:NTES) are both large-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, community ranking, valuation, earnings, analyst recommendations and media sentiment.
Genesis Healthcare currently has a consensus price target of $31.50, indicating a potential upside of 15.17%. NetEase has a consensus price target of $114.57, indicating a potential upside of 13.81%. Given Genesis Healthcare's higher probable upside, equities research analysts clearly believe Genesis Healthcare is more favorable than NetEase.
NetEase has higher revenue and earnings than Genesis Healthcare. NetEase is trading at a lower price-to-earnings ratio than Genesis Healthcare, indicating that it is currently the more affordable of the two stocks.
NetEase received 205 more outperform votes than Genesis Healthcare when rated by MarketBeat users. Likewise, 69.11% of users gave NetEase an outperform vote while only 65.43% of users gave Genesis Healthcare an outperform vote.
Genesis Healthcare pays an annual dividend of $0.50 per share and has a dividend yield of 1.8%. NetEase pays an annual dividend of $4.87 per share and has a dividend yield of 4.8%. Genesis Healthcare pays out 55.6% of its earnings in the form of a dividend. NetEase pays out 76.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Genesis Healthcare has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, NetEase has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500.
82.1% of Genesis Healthcare shares are held by institutional investors. Comparatively, 11.1% of NetEase shares are held by institutional investors. 3.3% of Genesis Healthcare shares are held by insiders. Comparatively, 54.7% of NetEase shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
In the previous week, NetEase had 10 more articles in the media than Genesis Healthcare. MarketBeat recorded 10 mentions for NetEase and 0 mentions for Genesis Healthcare. NetEase's average media sentiment score of 1.29 beat Genesis Healthcare's score of 0.00 indicating that NetEase is being referred to more favorably in the news media.
NetEase has a net margin of 28.17% compared to Genesis Healthcare's net margin of 17.83%. Genesis Healthcare's return on equity of 155.48% beat NetEase's return on equity.
Summary
NetEase beats Genesis Healthcare on 13 of the 20 factors compared between the two stocks.
Get Genesis Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Genesis Healthcare Competitors List
Related Companies and Tools
This page (NYSE:GEN) was last updated on 3/28/2025 by MarketBeat.com Staff
Buy GEN Stock Free GEN Stock Alerts